Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, ...
Data presented at European Molecular Imaging Meeting (EMIM 2025) for imaging with 68Ga-RAD202 confirms specific accumulation in the tumor, favorable biodistribution and low uptake in non-target organs ...
Cedric Pobel, MD, covers the PEACE-1 trial of radiotherapy, standard of care, and abiraterone in low-volume metastatic castration-sensitive prostate cancer.
The investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Dr. Tap previously led clinical trials for ...
Natera offers robust growth with strong financials and innovative tests. Find out why NTRA stock is a Buy, despite potential ...
The investigators reported that 67% of patients receiving vimseltinib had measurably reduced tumor volume, compared with none in the placebo group. Additionally, patients in the trial who received ...
It could be that keeping a diary — “keep” being the operative word — is how we stay true to ourselves, even the embarrassing ...
Pathologists is crucial in cancer care. However, the field faces challenges such as resource shortages, workflow ...
Lyell Immunopharma, Inc.’s LYEL share price has dipped by 11.67%, which has investors questioning if this is right time to buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback